YUMM1.7D5 MOUSE MELANOMA CELL LINE (C005B-315632)

General description

The YUMM3.3 mouse melanoma cell line was derived from a 4-hydroxytamoxifen-induced melanoma tumor in a female C57/B1/6 mouse into which mutations from the Braf/Pten genetically-engineered mouse model had been introduced via backcrossing. The YUMM3.3 cell line harbors the Braf V600E mutation and is homozygous negative for Cdkn2.1?

Application

• Each vial contains > 1X10⁶ viable cells.
• Cells are tested negative for infectious diseases by a Mouse Essential CLEAR panel by Charles River Animal Diagnostic Services.
• Cells are verified to be of mouse origin and negative for inter-species contamination from rat, chinese hamster, Golden Syrian hamster, human and non-human primate (NHP) as assessed by a Contamination CLEAR panel by Charles River Animal Diagnostic Services.
• Cells are negative for mycoplasma contamination.

Features and Benefits

The YUMM cell lines recapitulate genetic drivers found in many human melanomas. YUMM3.3 harbors the Braf V600E mutation and is homozygous negative for Cdkn2+.

Target description

The promise of immune-based therapies in cancer and increasingly successful application of these approaches have emphasized the necessity of immune-competent models to evaluate immunological responses to cancer cells. Immunocompetent genetically-engineered mouse models with distinct genetic drivers of melanoma are essential for identifying potential immunotherapies, but are limited by the need to maintain colonies of multiple genotypes necessary to generate mouse models with appropriate genetic backgrounds.YUMM3.3 cells are syngenic with the immunocompetent C57BL/6 mouse background and retain genetic markers of the Braf/Pten mouse model, characterized by activation of Braf and inactivation Cdkn2a. The YUMM3.3 cell line harbors wild-type Pten, allowing for comparative analysis for the parsing of distinct contributions of PI3K-Akt signaling in melanoma tumorigenesis and immune evasion. The YUMM3.3 mouse melanoma cell line represents a valuable tool for investigating the role of specific mutational profiles in melanomas and development of potential therapeutics.​Mutation: BrafV600E/wt Cdkn2−/−. Female.References:1. Meeth K et al. (2016) The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations. Pigment Cell Melanoma Res 29(5): 590-597.2. Dankort D et al. (2009) Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet. 41(5): 544-552.

Storage and Stability

Store in liquid nitrogen. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Shipping Information:

Hazmat Fee: $65.00 + applicable shipping charges are added after the order is placed.

More Information: https://cenmed.com/shipping-returns